Montelukast Prescribing at FIRS HOUSE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
766
Total Quantity
35.3K
NHS Cost
£1.7K
vs National Avg
+11.9%
FIRS HOUSE SURGERY prescribed 766 items of Montelukast over the last 12 months at a cost of £1,668 to the NHS. This is 11.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
63
Jun 2026
74
Jun 2026
66
Jun 2026
53
Jun 2026
64
Jun 2026
55
Jun 2026
68
Jun 2026
73
Jun 2026
62
Jun 2026
58
Jun 2026
66
Jun 2026
64
Prescribing Details
| Total Items | 766 |
|---|---|
| Total Quantity | 35,336 |
| Total NHS Cost | £1,668 |
| Presentations | 4 different forms |
| vs National Average | +11.9% |
Montelukast Prescribing Comparison
| This practice | 766 items |
|---|---|
| National average per practice | 685 items |
| Difference | +11.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.